Which has preferable earnings & valuation, NTRA or GH?

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Natera $2.31B 16.77 -$208.16M -$1.63 N/A Guardant Health $1.18B 18.28 -$416.28M -$3.49 N/A

Is NTRA or GH more profitable?

Natera has a net margin of -9.05% compared to Guardant Health's net margin of -38.33%. Guardant Health's return on equity of 0.00% beat Natera's return on equity. Company Net Margins Return on Equity Return on Assets Natera -9.05% -14.74% -10.27% Guardant Health -38.33% N/A -25.40%

Does the media favor NTRA or GH?

In the previous week, Guardant Health had 3 more articles in the media than Natera. MarketBeat recorded 37 mentions for Guardant Health and 34 mentions for Natera. Guardant Health's average media sentiment score of 0.97 beat Natera's score of 0.67 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 23 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 17 Very Positive mention(s) 2 Positive mention(s) 13 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer BTSG or NTRA?

In the previous week, Natera had 12 more articles in the media than BrightSpring Health Services. MarketBeat recorded 34 mentions for Natera and 22 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.91 beat Natera's score of 0.67 indicating that BrightSpring Health Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 8 Very Positive mention(s) 1 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Natera 23 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to NTRA or FMS?

In the previous week, Natera had 30 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 34 mentions for Natera and 4 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.78 beat Natera's score of 0.67 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 23 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fresenius Medical Care AG & Co. KGaA 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has higher earnings & valuation, NTRA or PACS?

PACS Group has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Natera $2.31B 16.77 -$208.16M -$1.63 N/A PACS Group $5.43B 1.32 $191.54M $1.56 29.05

Is NTRA or PACS more profitable?

PACS Group has a net margin of 4.49% compared to Natera's net margin of -9.05%. PACS Group's return on equity of 26.47% beat Natera's return on equity. Company Net Margins Return on Equity Return on Assets Natera -9.05% -14.74% -10.27% PACS Group 4.49% 26.47% 4.36%

Does the media favor NTRA or PACS?

In the previous week, Natera had 26 more articles in the media than PACS Group. MarketBeat recorded 34 mentions for Natera and 8 mentions for PACS Group. PACS Group's average media sentiment score of 1.16 beat Natera's score of 0.67 indicating that PACS Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 23 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, NTRA or HIMS?

Hims & Hers Health has higher revenue and earnings than Natera. Hims & Hers Health is trading at a lower price-to-earnings ratio than Natera, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Natera $2.31B 16.77 -$208.16M -$1.63 N/A Hims & Hers Health $2.37B 3.02 $128.37M -$0.09 N/A

Is NTRA or HIMS more profitable?

Hims & Hers Health has a net margin of -0.56% compared to Natera's net margin of -9.05%. Hims & Hers Health's return on equity of 6.10% beat Natera's return on equity. Company Net Margins Return on Equity Return on Assets Natera -9.05% -14.74% -10.27% Hims & Hers Health -0.56% 6.10% 1.52%

Does the media favor NTRA or HIMS?

In the previous week, Natera had 8 more articles in the media than Hims & Hers Health. MarketBeat recorded 34 mentions for Natera and 26 mentions for Hims & Hers Health. Natera's average media sentiment score of 0.67 beat Hims & Hers Health's score of 0.22 indicating that Natera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 23 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 5 Very Positive mention(s) 3 Positive mention(s) 10 Neutral mention(s) 5 Negative mention(s) 3 Very Negative mention(s) Neutral

Natera (NTRA) Competitors

$269.92 +2.16 (+0.81%)

As of 12:52 PM Eastern

Compare

NTRA vs. GH, BTSG, FMS, PACS, and HIMS

Should you buy Natera stock or one of its competitors? MarketBeat compares Natera with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Natera include Guardant Health (GH), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), PACS Group (PACS), and Hims & Hers Health (HIMS).

How does Natera compare to Guardant Health?

Natera (NASDAQ:NTRA) and Guardant Health (NASDAQ:GH) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, media sentiment, dividends and risk.

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natera	$2.31B	16.77	-$208.16M	-$1.63	N/A
Guardant Health	$1.18B	18.28	-$416.28M	-$3.49	N/A

99.9% of Natera shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 5.1% of Natera shares are owned by insiders. Comparatively, 5.6% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Guardant Health had 3 more articles in the media than Natera. MarketBeat recorded 37 mentions for Guardant Health and 34 mentions for Natera. Guardant Health's average media sentiment score of 0.97 beat Natera's score of 0.67 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natera	23 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardant Health	17 Very Positive mention(s)	2 Positive mention(s)	13 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Natera presently has a consensus price target of $267.83, suggesting a potential downside of 0.82%. Guardant Health has a consensus price target of $179.82, suggesting a potential upside of 10.28%. Given Guardant Health's stronger consensus rating and higher probable upside, analysts plainly believe Guardant Health is more favorable than Natera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natera	2 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	3 Strong Buy rating(s)	2.82
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	22 Buy rating(s)	1 Strong Buy rating(s)	2.96

Natera has a beta of 1.51, meaning that its share price is 51% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.59, meaning that its share price is 59% more volatile than the broader market.

Natera has a net margin of -9.05% compared to Guardant Health's net margin of -38.33%. Guardant Health's return on equity of 0.00% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natera	-9.05%	-14.74%	-10.27%
Guardant Health	-38.33%	N/A	-25.40%

Summary

Guardant Health beats Natera on 10 of the 17 factors compared between the two stocks.

How does Natera compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Natera (NASDAQ:NTRA) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.

BrightSpring Health Services has a net margin of 2.55% compared to Natera's net margin of -9.05%. BrightSpring Health Services' return on equity of 16.73% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.55%	16.73%	5.24%
Natera	-9.05%	-14.74%	-10.27%

BrightSpring Health Services currently has a consensus price target of $70.12, suggesting a potential upside of 13.91%. Natera has a consensus price target of $267.83, suggesting a potential downside of 0.82%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, equities analysts plainly believe BrightSpring Health Services is more favorable than Natera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	1 Hold rating(s)	18 Buy rating(s)	1 Strong Buy rating(s)	3.00
Natera	2 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	3 Strong Buy rating(s)	2.82

BrightSpring Health Services has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$14.37B	0.84	$190.67M	$1.66	37.08
Natera	$2.31B	16.77	-$208.16M	-$1.63	N/A

99.9% of Natera shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by insiders. Comparatively, 5.1% of Natera shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

BrightSpring Health Services has a beta of 1.79, meaning that its share price is 79% more volatile than the broader market. Comparatively, Natera has a beta of 1.51, meaning that its share price is 51% more volatile than the broader market.

In the previous week, Natera had 12 more articles in the media than BrightSpring Health Services. MarketBeat recorded 34 mentions for Natera and 22 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.91 beat Natera's score of 0.67 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	8 Very Positive mention(s)	1 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Natera	23 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

BrightSpring Health Services beats Natera on 12 of the 17 factors compared between the two stocks.

How does Natera compare to Fresenius Medical Care AG & Co. KGaA?

Natera (NASDAQ:NTRA) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Natera's net margin of -9.05%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natera	-9.05%	-14.74%	-10.27%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

Natera presently has a consensus price target of $267.83, indicating a potential downside of 0.82%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.95, indicating a potential downside of 7.22%. Given Natera's stronger consensus rating and higher probable upside, analysts clearly believe Natera is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natera	2 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	3 Strong Buy rating(s)	2.82
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55

99.9% of Natera shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 5.1% of Natera shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Natera has a beta of 1.51, suggesting that its share price is 51% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.77, suggesting that its share price is 23% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natera	$2.31B	16.77	-$208.16M	-$1.63	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.62	$1.11B	$1.90	13.59

In the previous week, Natera had 30 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 34 mentions for Natera and 4 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.78 beat Natera's score of 0.67 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natera	23 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care AG & Co. KGaA	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Natera beats Fresenius Medical Care AG & Co. KGaA on 9 of the 17 factors compared between the two stocks.

How does Natera compare to PACS Group?

Natera (NASDAQ:NTRA) and PACS Group (NYSE:PACS) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

Natera presently has a consensus target price of $267.83, suggesting a potential downside of 0.82%. PACS Group has a consensus target price of $50.60, suggesting a potential upside of 11.66%. Given PACS Group's higher probable upside, analysts plainly believe PACS Group is more favorable than Natera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natera	2 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	3 Strong Buy rating(s)	2.82
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

PACS Group has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natera	$2.31B	16.77	-$208.16M	-$1.63	N/A
PACS Group	$5.43B	1.32	$191.54M	$1.56	29.05

PACS Group has a net margin of 4.49% compared to Natera's net margin of -9.05%. PACS Group's return on equity of 26.47% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natera	-9.05%	-14.74%	-10.27%
PACS Group	4.49%	26.47%	4.36%

Natera has a beta of 1.51, indicating that its stock price is 51% more volatile than the broader market. Comparatively, PACS Group has a beta of -0.08, indicating that its stock price is 108% less volatile than the broader market.

In the previous week, Natera had 26 more articles in the media than PACS Group. MarketBeat recorded 34 mentions for Natera and 8 mentions for PACS Group. PACS Group's average media sentiment score of 1.16 beat Natera's score of 0.67 indicating that PACS Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natera	23 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

99.9% of Natera shares are owned by institutional investors. 5.1% of Natera shares are owned by insiders. Comparatively, 70.1% of PACS Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

PACS Group beats Natera on 10 of the 17 factors compared between the two stocks.

How does Natera compare to Hims & Hers Health?

Natera (NASDAQ:NTRA) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Hims & Hers Health has higher revenue and earnings than Natera. Hims & Hers Health is trading at a lower price-to-earnings ratio than Natera, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natera	$2.31B	16.77	-$208.16M	-$1.63	N/A
Hims & Hers Health	$2.37B	3.02	$128.37M	-$0.09	N/A

Hims & Hers Health has a net margin of -0.56% compared to Natera's net margin of -9.05%. Hims & Hers Health's return on equity of 6.10% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natera	-9.05%	-14.74%	-10.27%
Hims & Hers Health	-0.56%	6.10%	1.52%

99.9% of Natera shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 5.1% of Natera shares are held by insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Natera has a beta of 1.51, indicating that its share price is 51% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.35, indicating that its share price is 135% more volatile than the broader market.

Natera presently has a consensus price target of $267.83, indicating a potential downside of 0.82%. Hims & Hers Health has a consensus price target of $31.43, indicating a potential upside of 1.56%. Given Hims & Hers Health's higher possible upside, analysts plainly believe Hims & Hers Health is more favorable than Natera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natera	2 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	3 Strong Buy rating(s)	2.82
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

In the previous week, Natera had 8 more articles in the media than Hims & Hers Health. MarketBeat recorded 34 mentions for Natera and 26 mentions for Hims & Hers Health. Natera's average media sentiment score of 0.67 beat Hims & Hers Health's score of 0.22 indicating that Natera is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natera	23 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	5 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	5 Negative mention(s)	3 Very Negative mention(s)	Neutral

Summary

Hims & Hers Health beats Natera on 9 of the 17 factors compared between the two stocks.

Get Natera News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NTRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NTRA vs. The Competition

Export

Metric	Natera	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$38.71B	$3.52B	$6.80B	$12.66B
Dividend Yield	N/A	3.78%	2.59%	10.03%
P/E Ratio	-165.82	7.38	282.16	25.05
Price / Sales	16.77	1,220.59	576.18	79.91
Price / Cash	N/A	44.80	28.60	46.71
Price / Book	21.81	16.79	10.96	6.18
Net Income	-$208.16M	-$12.56M	$3.49B	$347.61M
7 Day Performance	4.65%	-0.84%	0.45%	0.71%
1 Month Performance	-3.32%	-7.59%	-4.26%	-3.75%
1 Year Performance	100.65%	49.20%	63.09%	20.17%

Natera Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NTRA Natera	2.7301 of 5 stars	$269.92 +0.8%	$267.83 -0.8%	+99.0%	$38.64B	$2.31B	N/A	6,140	Upcoming Earnings
GH Guardant Health	3.0582 of 5 stars	$145.47 -1.3%	$160.04 +10.0%	+291.1%	$19.54B	$982.02M	N/A	2,506	Analyst Forecast Gap Down
BTSG BrightSpring Health Services	4.9073 of 5 stars	$71.98 -1.3%	$70.12 -2.6%	+204.0%	$14.38B	$12.91B	51.05	23,500	Positive News Earnings Report Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	3.842 of 5 stars	$24.90 +1.3%	$28.00 +12.4%	+2.2%	$13.21B	$22.20B	13.11	1,488	Positive News Upcoming Earnings
PACS PACS Group	3.5397 of 5 stars	$46.95 +0.2%	$50.60 +7.8%	+334.3%	$7.42B	$5.29B	30.09	47,455	Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NTRA) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Natera (NTRA) Competitors

NTRA vs. GH, BTSG, FMS, PACS, and HIMS

How does Natera compare to Guardant Health?

Summary

How does Natera compare to BrightSpring Health Services?

Summary

How does Natera compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Natera compare to PACS Group?

Summary

How does Natera compare to Hims & Hers Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTRA vs. The Competition

Natera Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Natera (NTRA) Competitors

NTRA vs. GH, BTSG, FMS, PACS, and HIMS

How does Natera compare to Guardant Health?

Which has preferable earnings & valuation, NTRA or GH?

Do insiders & institutionals have more ownership in NTRA or GH?

Does the media favor NTRA or GH?

Do analysts rate NTRA or GH?

Which has more volatility & risk, NTRA or GH?

Is NTRA or GH more profitable?

Summary

How does Natera compare to BrightSpring Health Services?

Is BTSG or NTRA more profitable?

Do analysts prefer BTSG or NTRA?

Which has better earnings and valuation, BTSG or NTRA?

Do insiders and institutionals have more ownership in BTSG or NTRA?

Which has more volatility & risk, BTSG or NTRA?

Does the media prefer BTSG or NTRA?

Summary

How does Natera compare to Fresenius Medical Care AG & Co. KGaA?

Is NTRA or FMS more profitable?

Do analysts prefer NTRA or FMS?

Do insiders & institutionals hold more shares of NTRA or FMS?

Which has more volatility and risk, NTRA or FMS?

Which has stronger valuation & earnings, NTRA or FMS?

Does the media refer more to NTRA or FMS?

Summary

How does Natera compare to PACS Group?

Do analysts rate NTRA or PACS?

Which has higher earnings & valuation, NTRA or PACS?

Is NTRA or PACS more profitable?

Which has more risk & volatility, NTRA or PACS?

Does the media favor NTRA or PACS?

Do insiders and institutionals hold more shares of NTRA or PACS?

Summary

How does Natera compare to Hims & Hers Health?

Which has better earnings and valuation, NTRA or HIMS?

Is NTRA or HIMS more profitable?

Do insiders and institutionals believe in NTRA or HIMS?

Which has more risk and volatility, NTRA or HIMS?

Do analysts recommend NTRA or HIMS?

Does the media favor NTRA or HIMS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTRA vs. The Competition

Natera Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools